Literature DB >> 10204844

A clinical study of type 1 neurofibromatosis in north west England.

J M McGaughran1, D I Harris, D Donnai, D Teare, R MacLeod, R Westerbeek, H Kingston, M Super, R Harris, D G Evans.   

Abstract

A clinical study of patients on the North West Regional Genetic Register with neurofibromatosis type 1 (NF1) identified 523 affected cases from 304 families. In those for whom relevant information was available, 86.7% (383 of 442) had more than six café au lait patches, 83.8% (310 of 370) had axillary freckling, 42.3% (151 of 357) had inguinal freckling, and 63% (157 of 249) had Lisch nodules. Cutaneous neurofibromas were present in 59.4% (217 of 365) and 45.5% (150 of 330) were noted to have subcutaneous tumours. Plexiform neurofibromas were present in 15.3% (80 of 523). A positive family history of NF1 was found in 71.2% (327 of 459) and 28.8% (132 of 459) of affected patients were considered to be the result of a new mutation. Learning difficulties of varying severity occurred in 62% (186 of 300). CNS tumours associated with NF1 were reported in 9.4% (49) of patients, optic gliomas occurring in 25 of these, 4.8% of patients. Some degree of scoliosis was reported for 11.7% (61), 1.9% (10) had pseudoarthrosis, 4.3% (23) had epilepsy, and 2.1% (11) had spinal neurofibromas. Actuarial analyses were carried out for both optic glioma and malignant nerve sheath tumours and the data are presented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10204844      PMCID: PMC1734324     

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  Iris (Lisch) nodules in neurofibromatosis.

Authors:  C Zehavi; A Romano; R M Goodman
Journal:  Clin Genet       Date:  1986-01       Impact factor: 4.438

2.  Optic glioma of childhood. Natural history and rationale for conservative management.

Authors:  W F Hoyt; S A Baghdassarian
Journal:  Br J Ophthalmol       Date:  1969-12       Impact factor: 4.638

3.  Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.

Authors:  B R Seizinger; G A Rouleau; L J Ozelius; A H Lane; A G Faryniarz; M V Chao; S Huson; B R Korf; D M Parry; M A Pericak-Vance
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

4.  Genetic linkage studies with neurofibromatosis: the question of heterogeneity.

Authors:  M A Spence; R S Sparkes; D M Parry; S J Bale; V Cortessis; J J Mulvihill
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

5.  von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

Authors:  R A Lewis; L P Gerson; K A Axelson; V M Riccardi; R P Whitford
Journal:  Ophthalmology       Date:  1984-08       Impact factor: 12.079

6.  Clinical and genetic investigations into tuberous sclerosis and Recklinghausen's neurofibromatosis; contribution to elucidation of interrelationship and eugenics of the syndromes.

Authors:  A BORBERG
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1951

7.  Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.

Authors:  D E Goldgar; P Green; D M Parry; J J Mulvihill
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

8.  Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata.

Authors:  R A Lewis; V M Riccardi
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

9.  Neurofibromatosis. A clinical and genetic study of 96 cases in Gothenburg, Sweden.

Authors:  B Samuelsson; R Axelsson
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1981

10.  Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants.

Authors:  V M Riccardi; R A Lewis
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

View more
  54 in total

Review 1.  Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

Authors:  D G R Evans; J M Birch; R T Ramsden; S Sharif; M E Baser
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

2.  MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.

Authors:  V F Mautner; M Hartmann; L Kluwe; R E Friedrich; C Fünsterer
Journal:  Neuroradiology       Date:  2006-01-24       Impact factor: 2.804

Review 3.  Large Cervical Vagus Nerve Tumor in a Patient with Neurofibromatosis Type 1 Treated with Gross Total Resection: Case Report and Review of the Literature.

Authors:  David P Bray; Andrew K Chan; Cynthia T Chin; Line Jacques
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2016-11-16

4.  Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types.

Authors:  Eungu Kang; Yoon-Myung Kim; Go Hun Seo; Arum Oh; Hee Mang Yoon; Young-Shin Ra; Eun Key Kim; Heyry Kim; Sun-Hee Heo; Gu-Hwan Kim; Mark J Osborn; Jakub Tolar; Han-Wook Yoo; Beom Hee Lee
Journal:  J Hum Genet       Date:  2019-11-28       Impact factor: 3.172

Review 5.  Neurofibromatosis type 2.

Authors:  D G Evans; M Sainio; M E Baser
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

Review 6.  Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.

Authors:  P Björklund; K Pacak; J Crona
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

7.  Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1.

Authors:  Reinhard E Friedrich; Caglayan T Tuzcu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

8.  18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off.

Authors:  Johannes Salamon; Simon Veldhoen; Ivayla Apostolova; Peter Bannas; Jin Yamamura; Jochen Herrmann; Reinhard E Friedrich; Gerhard Adam; Victor F Mautner; Thorsten Derlin
Journal:  Eur Radiol       Date:  2013-10-05       Impact factor: 5.315

9.  Plexiform neurofibroma in the hepatic hilum associated with neurofibromatosis type 1: a case report.

Authors:  Sojun Hoshimoto; Zenichi Morise; Chinatsu Takeura; Masahiro Ikeda; Tadashi Kagawa; Yoshinao Tanahashi; Yasuhiro Okabe; Yoshikazu Mizoguchi; Atsushi Sugioka
Journal:  Rare Tumors       Date:  2009-07-22

10.  Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.

Authors:  Matthias R Benz; Johannes Czernin; Sarah M Dry; William D Tap; Martin S Allen-Auerbach; David Elashoff; Michael E Phelps; Wolfgang A Weber; Fritz C Eilber
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.